Oxidative Stress-Mediated Neuroinflammation in the Pathophysiology of Schizophrenia
Open Access
- 18 November 2025
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (22) , 11139
Abstract
Schizophrenia is a complex neuropsychiatric disorder characterized by a diverse range of symptoms, including positive, negative symptoms such as alogia, anhedonia, avolition, and affective flattening, cognitive symptoms, and emotional symptoms as a separate domain. Emerging evidence suggests that oxidative stress and neuroinflammation play crucial roles in the etiopathogenesis of schizophrenia. The aim of this review is the interplay between oxidative stress—defined as an imbalance between reactive oxygen species (ROS) production and antioxidant defenses—and neuroinflammatory processes within the central nervous system. Studies indicate that elevated levels of oxidative markers and pro-inflammatory cytokines are commonly observed in individuals with schizophrenia, pointing to a potential pathophysiological link. The dysregulation of redox homeostasis may exacerbate neuroinflammatory responses, contributing to neuronal damage and the subsequent manifestation of psychiatric symptoms. Furthermore, genetic and environmental factors may interact with these biological processes, influencing individual susceptibility to schizophrenia. Understanding the mechanisms by which oxidative stress and neuroinflammation contribute to the development and progression of schizophrenia could pave the way for novel therapeutic strategies aimed at mitigating these pathological processes and improving patient outcomes.Keywords
This publication has 164 references indexed in Scilit:
- Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and agingArchives of Toxicology, 2023
- Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric DisordersJAMA Psychiatry, 2022
- Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disordersCellular and Molecular Life Sciences, 2021
- Dopamine and glutamate in schizophrenia: biology, symptoms and treatmentWorld Psychiatry, 2020
- Genetic variability of serotonin pathway associated with schizophrenia onset, progression, and treatmentAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2019
- Acetylsalicylic acid (aspirin) for schizophreniaCochrane Database of Systematic Reviews, 2019
- Inflammatory Biomarkers and Risk of SchizophreniaJAMA Psychiatry, 2017
- Nature of Glutamate Alterations in SchizophreniaJAMA Psychiatry, 2016
- Antioxidant treatments for schizophreniaCochrane Database of Systematic Reviews, 2016
- Interactions between mitochondrial reactive oxygen species and cellular glucose metabolismArchives of Toxicology, 2015